Anxiety News and Research RSS Feed - Anxiety News and Research

Anxiety disorder is a mental ailment that leads to unnecessary anxiety over different activities and events.
Manic symptoms during depression warn of polarity switch

Manic symptoms during depression warn of polarity switch

Concomitant manic symptoms and panic attacks are the strongest predictors of an impending switch to mania among patients with bipolar disorder who are currently depressed, shows analysis of the STEP-BD study. [More]
Addiction history indicates bipolar conversion risk from precursor disorders

Addiction history indicates bipolar conversion risk from precursor disorders

Substance use and the presence of subthreshold affective symptoms may predict future bipolar disorder in young people with precursor conditions such as depression, research suggests. [More]
Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Responding to rapidly shifting legal and cultural environments, researchers at the University of Montreal and CHU Sainte-Justine Children's Hospital have found a way to prevent, reduce or delay cannabis use amongst some at-risk youth. Cannabis users are at risk of neurocognitive deficits, reduced educational and occupational attainment, motor vehicle accidents, exacerbation of psychiatric symptoms, and precipitation of psychosis. [More]
Depression increases risk of mortality in patients with heart failure

Depression increases risk of mortality in patients with heart failure

Moderate to severe depression is associated with a 5-fold increased risk of all cause mortality in patients with heart failure, according to research presented today at Heart Failure 2015. The results from OPERA-HF show that risk was independent of comorbidities and severity of heart failure. Patients who were not depressed had an 80% lower mortality risk. [More]
Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015. [More]
Teens with slower cognitive processing speed experience depression, anxiety symptoms as adults

Teens with slower cognitive processing speed experience depression, anxiety symptoms as adults

Teens with slower performance on a test of "cognitive processing speed" are more likely to have depression and anxiety symptoms as adults, reports a paper in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. [More]

Magstim Rapid2 Therapy System receives FDA clearance for treatment of drug resistant MDD

The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, has received FDA 510(k) clearance to market its Magstim Rapid2 Therapy System for the treatment of drug resistant Major Depressive Disorder (MDD) in the United States. The clearance enables Magstim to significantly increase access to cutting-edge Repetitive Transcranial Magnetic Stimulation (rTMS) technology for patients and clinicians. [More]

NIDEK announces launch of HandyRef-K / HandyRef for accurate refraction, keratometry measurements

NIDEK CO. LTD., a global leader in the design, manufacturing, and distribution of ophthalmic, optometric, and lens edging equipment, will launch the HandyRef-K / HandyRef in May 2015. [More]
New research project aims at preventing HIV, other blood-borne infections

New research project aims at preventing HIV, other blood-borne infections

Research consistently shows that policing practices, such as confiscating or breaking needles, are key factors in the HIV epidemic among persons who inject drugs. Police officers themselves are also at risk of acquiring HIV or viral hepatitis if they experience needle-stick injuries on the job — a significant source of anxiety and staff turn-over. [More]
Catasys' total revenues increase 118% to $433,000 in first quarter 2015

Catasys' total revenues increase 118% to $433,000 in first quarter 2015

Catasys, Inc., provider of proprietary health management services to health insurers and employers, today reported its first quarter 2015 financial results for the period ended March 31, 2015. [More]
Discovery has clear implications in the quest for new epilepsy treatments

Discovery has clear implications in the quest for new epilepsy treatments

The mission of neural stem cells located in the hippocampus, one of the main regions of the brain, is to generate new neurons during the adult life of mammals, including human beings, of course, and their function is to participate in certain types of learning and responses to anxiety and stress. [More]
CME Medical to distribute eZono 4000 for use in multiple clinical settings

CME Medical to distribute eZono 4000 for use in multiple clinical settings

CME Medical, the market leader in the specialist infusion pump field, is delighted to announce its partnership with eZono, AG, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono 4000. [More]
UMD study examines link between mental health and the Great Recession

UMD study examines link between mental health and the Great Recession

Men and women in the U.S. had lower odds of depression diagnoses and better mental health during the Great Recession of 2007-09 compared to pre-recession according to a University of Maryland study published in the journal PLOS ONE. [More]
Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

The Brain & Behavior Research Foundation today announced its 2015 Independent Investigator Grants which will award $3.9 million in funding to 40 mid-career scientists from 30 institutions in 16 countries. [More]
Hallucinations, delusions associated with psychiatric disorders seldom trigger violent crimes

Hallucinations, delusions associated with psychiatric disorders seldom trigger violent crimes

Mass shootings at the hands of unhinged loners - such as those in Aurora, Colorado; Santa Barbara, California, and Newtown, Connecticut - perpetuate a commonly held belief that mental illness triggers violent crimes. [More]
Major breakthrough provides new insights into how tinnitus develops

Major breakthrough provides new insights into how tinnitus develops

Tinnitus is the most common service-related disability for veterans returning from Iraq and Afghanistan. Often described as a ringing in the ears, more than 1.5 million former service members, one out of every two combat veterans, report having this sometimes debilitating condition, resulting in more than $2 billion dollars in annual disability payments by the U.S. Department of Veterans Affairs. [More]
Catatonia may cause regression in Down syndrome patients

Catatonia may cause regression in Down syndrome patients

Down syndrome, the most common chromosomal disorder in America, can be complicated by significant deterioration in movement, speech and functioning in some adolescents and young adults. Physicians previously attributed this regression to depression or early-onset Alzheimer's, and it has not responded to treatments. [More]
Going to the dentist just got a little less scary for U.S. children with autism

Going to the dentist just got a little less scary for U.S. children with autism

Going to the dentist might have just gotten a little less scary for the estimated 1 in 68 U.S. children with autism spectrum disorder as well as children with dental anxiety, thanks to new research from USC. [More]
Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics, Inc. today announced business and financial results for the first quarter ended March 31, 2015. [More]

New Griffith research program aims to reduce negative impact of anxiety

Combatting the negative impact of anxiety using cognitive behavioural therapy is the aim of a new research program run by Griffith University, in the face of this significant issue. [More]
Advertisement